Thomas Trimarchi
President and CFO at Bridgebio Pharma · 15 reported transactions in 1 company · latest trade May 18, 2026
Their trades
Sold | May 18, 2026 | May 18, 2026 close $65.32 → Oct 26, 2026 close $68.15. S&P 500 +3.6% over the same days. | ||
Sold | May 18, 2026 | May 18, 2026 close $65.32 → Oct 26, 2026 close $68.15. S&P 500 +3.6% over the same days. | ||
Sold | Feb 17, 2026 | Feb 17, 2026 close $75.85 → Oct 26, 2026 close $68.15. S&P 500 +12.1% over the same days. | ||
Sold | Feb 17, 2026 | Feb 17, 2026 close $75.85 → Oct 26, 2026 close $68.15. S&P 500 +12.1% over the same days. | ||
Sold | Nov 17, 2025 | Nov 17, 2025 close $66.90 → Oct 26, 2026 close $68.15. S&P 500 +15.0% over the same days. | ||
Sold | Nov 17, 2025 | Nov 17, 2025 close $66.90 → Oct 26, 2026 close $68.15. S&P 500 +15.0% over the same days. |
SoldBridgebio Pharma
$210.7K
May 18, 2026 close $65.32 → Oct 26, 2026 close $68.15. S&P 500 +3.6% over the same days.
SoldBridgebio Pharma
$677.7K
May 18, 2026 close $65.32 → Oct 26, 2026 close $68.15. S&P 500 +3.6% over the same days.
SoldBridgebio Pharma
$15.1K
Feb 17, 2026 close $75.85 → Oct 26, 2026 close $68.15. S&P 500 +12.1% over the same days.
SoldBridgebio Pharma
$1M
Feb 17, 2026 close $75.85 → Oct 26, 2026 close $68.15. S&P 500 +12.1% over the same days.
SoldBridgebio Pharma
$464.9K
Nov 17, 2025 close $66.90 → Oct 26, 2026 close $68.15. S&P 500 +15.0% over the same days.
SoldBridgebio Pharma
$660.5K
Nov 17, 2025 close $66.90 → Oct 26, 2026 close $68.15. S&P 500 +15.0% over the same days.